Zinc mesoporphyrin

Star0

DB17694ExperimentalSmall molecule

Zinc mesoporphyrin: Overview.

Formula / weight: C₃₄H₃₆N₄O₄Zn · 630.07 g/mol (avg)
Also known as: 21h,23h-porphine-2,18-dipropanoic acid, 7,12-diethyl-3,8,13,17-tetramethyl-, zinc complex · Zinc (II) mesoporphyrin IX · Zinc mesoporphyrin ix · Zincate(2-), (7,12-diethyl-3,8,13,17-tetramethyl-21h,23h-porphine-2,18-dipropanoato(4-)-.kappa.n21,.kappa.n22,.kappa.n23,.kappa.n24)-, hydrogen (1:2), (sp-4-2)- · Zn(II) mesoporphyrin IX
Code names: NSC-26741

Resolves to

Compound

UNII99LY10G7K9CAS14354-67-7

Structure

InChIKeyYQJXHPBQEBGWBG-RGGAHWMASA-LSMILES[Zn++].CCC1=C(C)/C2=C/C3=N/C(=C\C4=C(CCC(O)=O)C(C)=C([N-]4)/C=C4\N=C(\C=C\1/[N-]\2)C(C)=C4CC)/C(CCC(O)=O)=C3C

Transporters

Q9UNQ0ABCG2

What you can answer from here — as of August 14, 2026

1TransporterSubstrate / inhibitor direction, not just membership

Listed above

4+ReferencesStructured and connected to the statements they support

Which companies are running trials of Zinc mesoporphyrin, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account